Woodline Partners’s Freeline Therapeutics Holdings FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,729
Closed -$51K – 854
2021
Q4
$51K Hold
1,729
– – ﹤0.01% 630
2021
Q3
$89K Hold
1,729
– – ﹤0.01% 588
2021
Q2
$211K Hold
1,729
– – ﹤0.01% 489
2021
Q1
$319K Hold
1,729
– – 0.01% 402
2020
Q4
$474K Sell
1,729
-12,032
-87% -$3.02M 0.01% 214
2020
Q3
$3.22M Buy
+13,761
New +$3.45M 0.11% 150

Other funds holding FRLN

Woodline Partners's FRLN Position: Q1 2022 in Review

Woodline Partners sold out of Freeline Therapeutics Holdings (FRLN) in Q1 2022, closing a stake of 1,729 shares — an estimated $51K sold.

Woodline Partners first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $3.22M in Q3 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

  • Woodline Partners reported no remaining Freeline Therapeutics Holdings position as of Q1 2022 after selling out during the quarter.
  • Woodline Partners sold 1,729 Freeline Therapeutics Holdings shares in Q1 2022, an estimated $51K.
  • Woodline Partners first reported a position in Freeline Therapeutics Holdings in Q3 2020 and held it in 6 quarters.
  • Woodline Partners's Freeline Therapeutics Holdings position peaked at $3.22M in Q3 2020.
  • 19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q1 2022.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.